{"id":15699,"date":"2026-03-24T08:41:00","date_gmt":"2026-03-24T08:41:00","guid":{"rendered":"http:\/\/www.mark-sheldon.com\/twitter-stream\/china-intramuscular-generic-injection-qlg2072-versus-haloperidol-in-chinese-patients-w\/"},"modified":"2026-04-03T17:14:02","modified_gmt":"2026-04-03T17:14:02","slug":"china-intramuscular-generic-injection-qlg2072-versus-haloperidol-in-chinese-patients-w","status":"publish","type":"post","link":"http:\/\/www.mark-sheldon.com\/twitter-stream\/china-intramuscular-generic-injection-qlg2072-versus-haloperidol-in-chinese-patients-w\/","title":{"rendered":"China &#8211; Intramuscular Generic Injection (QLG2072) versus Haloperidol in Chinese Patients w\u2026"},"content":{"rendered":"<p>China &#8211; Intramuscular Generic Injection (QLG2072) versus Haloperidol in Chinese Patients with Acute Agitation. More specialist, but interesting for those watching acute disturbance management research. <a href=\"https:\/\/buff.ly\/SAldoZe\" rel=\"noopener\" target=\"_blank\">buff.ly\/SAldoZe<\/a><\/p>\n<p><a href=\"https:\/\/x.com\/Mark_Sheldon\/status\/2036362636321800542\" rel=\"noopener\" target=\"_blank\">View on X &#x2197;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China &#8211; Intramuscular Generic Injection (QLG2072) versus Haloperidol in Chinese Patients with Acute Agitation. More specialist, but interesting for those watching acute disturbance management research. buff.ly\/SAldoZe View on X &#x2197;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"status","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-15699","post","type-post","status-publish","format-status","hentry","category-tweets","post_format-post-format-status"],"_links":{"self":[{"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/posts\/15699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/comments?post=15699"}],"version-history":[{"count":1,"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/posts\/15699\/revisions"}],"predecessor-version":[{"id":15732,"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/posts\/15699\/revisions\/15732"}],"wp:attachment":[{"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/media?parent=15699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/categories?post=15699"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.mark-sheldon.com\/twitter-stream\/wp-json\/wp\/v2\/tags?post=15699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}